Sangamo Therapeutics Inc. (SGMO): Share Price, Stock Analysis, Annual Report | Value Research Get Sangamo Therapeutics Inc. (SGMO)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

Sangamo Therapeutics Inc. (SGMO)

NASDAQ: SGMO

  • Market Capitalisation info

    $991 Mln


  • 12 Month Earnings info

    $-176 Mln

  • Price to Earnings info

    --

$6.15

As on 16-Aug-2022 13:41 EDT

up-down-arrow $-0.25-3.83%

  • Prev Close info

    $6.39

  • Day's Openinfo

    $6.34

  • Today's Highinfo

    $6.34

  • Today's Lowinfo

    $6.07

  • Today's Volumeinfo

    512,375

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sangamo Therapeutics (SGMO)
-18.07 35.35 52.86 -38.86 -17.77 -11.31 1.24
S&P BSE Sensex
2.73 11.31 13.35 7.95 17.05 13.73 12.94
S&P Small-Cap 600
-7.09 14.53 9.50 -3.52 13.13 9.30 11.14
As on 16-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Sangamo Therapeutics (SGMO)
-51.94 86.44 -27.09 -29.86 437.70 -66.59 -39.97
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        CEO, Pres & Director

        Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.

        Sr. VP, CFO & Principal Accounting Officer

        Ms. Prathyusha Duraibabu CPA, M.B.A.

        Headquarters

        Brisbane, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $990.98 Mln

        • Revenue (TTM) info

          $112.65 Mln

        • Earnings (TTM) info

          $-176.33 Mln

        • Cash info

          $317.80 Mln

        • Total Debt info

          $42.82 Mln

        • Insider's Holding

          16.91%

        • Liquidity info

          Low

        • 52 Week range info

          $3.12 - 11.49

        • Shares outstanding info

          146,687,008

        • 10 Years Aggregate:

          CFO: $-292.29 Mln

          EBITDA: $-661.98 Mln

          Net Profit: $-705.04 Mln

        About The Company

        • Business

          Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation.

        • IPO Date

          06-Apr-2000

        • CEO, Pres & Director

          Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.

        • Sr. VP, CFO & Principal Accounting Officer

          Ms. Prathyusha Duraibabu CPA, M.B.A.

        • Listing info

          NASDAQ: SGMO

        • Country

          United States

        • Headquarters info

          Brisbane, CA

        • Website info

          https://www.sangamo.com